C125PM is a human colorectal adenocarcinoma cell line. Colorectal cancer (CRC) cell lines are widely used pre-clinical model systems.
| Inventor | Institute |
|---|---|
| Walter Bodmer | Cancer Research UK, London Research Institute: Lincoln's Inn Fields |
| SKU: | 151763 |
|---|---|
| Product description: | C125PM is a human colorectal adenocarcinoma cell line. |
| Conditional: | Yes |
| Cellosaurus ID: | CVCL_8175 |
| Disease: | Cancer |
| Cat. #: | 151763 |
|---|---|
| Provenance and Ownership: | The C125PM Colorectal Cell Line is owned by Cancer Research UK. CancerTools supplies the C125PM Colorectal Cell Line under licence from Cancer Research UK and is the authorised source for its distribution. Sourcing C125PM Colorectal Cell Line directly from the IP owner ensures authenticity, provenance and compliance with all applicable licensing and research use requirements. |
| Unit size: | 1×10^6 cells / vial |
| Cancer types: | Colorectal cancer |
| Research Fields: | Cancer; Drug development |
| Organism: | Human |
| Tissue: | Colon |
| Model: | Tumour line |
| Cancer Types In Detail: | Adenocarcinoma |
| Format: | Frozen |
|---|---|
| Shipping conditions: | Dry ice |
| Growth medium: | Split sub-confluent cultures (70-80%) 1:3 to 1:6 i.e. seeding at 2-4×10,000 cells/cm? using 0.05% trypsin or trypsin/EDTA; 5% CO2; 37?°C. |
| References: |
Rowan et al. 2000. Proc Natl Acad Sci U S A. 97(7):3352-7. PMID: 10737795. APC mutations in sporadic colorectal tumors: A mutational "hotspot" and interdependence of the "two hits". |
|---|
C125PM cell line growth profile. Medium changed at 70 hours. Image courtesy of European Collection of Authenticated Cell Cultures (ECACC).
C125PM Colorectal Cell Line. 7 d post plating. Image courtesy of the European Collection of Authenticated Cell Cultures (ECACC)


Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.